Changchuan Jiang, MD, MPH, on Transportation Barriers, Delays in Cancer Care, and Increased Mortality for Patients With Cancer

2022 ASCO Quality Care Symposium


Changchuan Jiang, MD, MPH, of Roswell Park Comprehensive Cancer Center, discusses the lack of transportation as a potentially modifiable barrier to care for patients with cancer. Timely intervention may reduce visits to hospital emergency departments, lower costs, and improve outcomes (Abstract 70).


Disclaimer: This video transcript has not been proofread or edited and may contain errors.
We know that cancer survivor are a very unique population, where is going very rapidly, over the past few years, due to the aging trend and advancing cancer treatment. On the same time, this is a really a vulnerable group with increased medical needs, more comorbidities, and increased health service use. Notably, our previous studies suggest that cancer survivor experience more difficulty with transportations, compared to adults without a cancer history. In this study, we really look at the cancer survivor and their transportation barrier and how these barriers impact their clinical outcomes. For example, we focus on their transportation barrier as the patient self-report delay in care, due to lack of transportation, and we also look at if they have a routine place for care and if they visit emergency room over the past 12 months. And we also look at their overall survival and cause-specific mortality, including cancer-specific mortalities. We find that cancer survivors experience a way higher risk of visiting emergency room and the lack of routine place for care when they experiencing difficulty with transportation. At same times, this vulnerable group of patients, once facing the transportation barrier, experience the highest risk of dying from any disease, and cancer, specifically. Our studies suggest it's very important to pay attention to the transportation, a issue that faced by patient and physician every single day. And really look at this and ask our patients, "Are you experiencing any difficulty getting to the clinic?" We don't want them to stay at home just because they don't have transportation. Then this problem will get larger, and they will experience worse outcome after that. We believe it's very important for us to screen, identify, and mitigate these barriers, and it will potentially improve the patients' outcome, reduce the health service use, and potentially save cost.

Related Videos

Symptom Management
Supportive Care

Sandra L. Wong, MD, on Severe Symptom Reporting in Patients With Cancer Who Have Undergone Surgery

Sandra L. Wong, MD, of the Dartmouth-Hitchcock Medical Center, discusses her study findings showing that when patients with cancer who have had surgery reported severe symptoms via an electronic patient-reported outcomes questionnaire at six cancer centers, it appeared to be beneficial without overtaxing clinicians. There were few strong predictors of severe symptoms, which suggests population surveillance may be preferable to targeted surveillance (Abstract 243).

Issues in Oncology

Jensa C. Morris, MD: Oncology Hospitalist Co-Management May Be Linked to Efficient, High-Quality Care and Education

Jensa C. Morris, MD, of the Yale School of Medicine, Smilow Hospitalist Service, discusses her findings on the benefits of hospitalist co-management of patients with cancer: It reduced the length of hospital stay by 1 day, increased early discharge (before 11:00 AM) by threefold; raised the educational rankings of house staff, and lowered oncologists’ stress level, improving their ability to manage competing responsibilities (Abstract 1).

Colorectal Cancer

S.M. Qasim Hussaini, MD, on Colon Cancer Treatment Outcomes and Historical Housing Discrimination

S. M. Qasim Hussaini, MD, of the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, discusses findings from a nationwide study of the association between living in areas with discriminatory mortgage practices from the 1930s with present-day access to quality colon cancer care. The study underscores the importance of state- and federal-level practices on mortgage lending regulation and fair housing practices in determining equitable cancer risk, access to care, and outcomes (Abstract 69).

Issues in Oncology

Samyukta Mullangi, MD, MBA, on Predictors of Compliance With Payer-Led Oncology Clinical Pathways

Samyukta Mullangi, MD, MBA, of Memorial Sloan Kettering Cancer Center, discusses her findings showing that physicians’ prescribing behavior may be influenced by payer-led pathways. Pathway compliance was associated with higher medical costs during a 6-month baseline period but lower health-care utilization, as measured in hospitalizations and emergency department visits during that baseline period (Abstract 7).

Health-Care Policy

Justin M. Barnes, MD, on Medicaid Expansion and Changes in Cancer Mortality Rates

Justin M. Barnes, MD, of the Washington University School of Medicine, discusses the ways in which Medicaid expansion under the Affordable Care Act seems to affect distant diagnoses and cancer deaths per year, the differences in the impact of expansion between Black and White patients in the United States, and why insurance alone appears to be insufficient to overcome structural barriers to care for some populations.